|
HS Code |
531484 |
| Productname | 4-Bromo-2,3-Difluorobenzeneboronic Acid |
| Molecularformula | C6H4BrBF2O2 |
| Casnumber | 849062-14-0 |
| Appearance | White to off-white solid |
| Purity | Typically >97% |
| Solubility | Soluble in organic solvents (e.g., DMSO, methanol) |
| Smiles | B(C1=CC(=C(C=C1F)F)Br)(O)O |
| Inchi | InChI=1S/C6H4BrBF2O2/c7-3-1-2-4(8(11)12)6(10)5(3)9/h1-2,11-12H |
| Storageconditions | Store at 2-8°C, protected from light and moisture |
As an accredited 4-Bromo-2,3-Difluorobenzeneboronic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The 5-gram 4-Bromo-2,3-difluorobenzeneboronic acid comes in a sealed amber glass bottle with a tamper-evident cap and label. |
| Shipping | 4-Bromo-2,3-Difluorobenzeneboronic Acid is shipped in sealed, chemically-resistant containers to prevent moisture and air exposure. It is packaged in compliance with relevant safety regulations, often including hazardous material labeling. Shipping typically follows ground or air freight standards for laboratory chemicals, ensuring product integrity and safety during transit. |
| Storage | **4-Bromo-2,3-Difluorobenzeneboronic Acid** should be stored in a tightly sealed container, protected from moisture and light. Keep it in a cool, dry, and well-ventilated area, typically at 2-8°C (refrigerated), away from incompatible substances like strong oxidizers and acids. Handle under inert atmosphere (e.g., nitrogen or argon) if possible, to prevent degradation and maintain chemical stability. |
Applications of 4-Bromo-2,3-Difluorobenzeneboronic Acid in Industrial ManufacturingAs a direct manufacturer, we supply 4-Bromo-2,3-Difluorobenzeneboronic Acid to established industries focused on high-value, regulated downstream products. Our material undergoes strict internal QC to ensure reliable integration in advanced chemical syntheses. The scenarios below outline industrial usage with specific compliance, formulation, production process, and finished goods information. 1. Pharmaceutical API Intermediate SynthesisDrug manufacturers employ this boronic acid compound as a key intermediate for targeted Suzuki-Miyaura cross-coupling reactions, specifically in the synthesis of fluorinated aromatic pharmaceuticals. Companies typically use it for installing difluoro and bromo functional motifs in active pharmaceutical ingredients (APIs) governed by regulatory filings. Batch controls and traceability are maintained for every delivery to support drug master file requirements. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Active Ingredient ProductionAgrochemical formulators require this boronic acid derivative to introduce precise bromo and difluorophenyl groups in next-generation herbicide and pesticide molecules. Its consistent reactivity supports large-scale couplings where stability and reproducibility of the active site are critical. Formulation teams adjust input levels according to the targeted regulatory approvals for end products. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Specialty Electronic Chemicals for OLED and TFT MaterialsProducers in the display and electronics sectors integrate this compound for the controlled synthesis of high-performance organic building blocks. It enables reliable incorporation of difluoro and bromo substituents required in organic semiconductors and light emitting materials. Raw material control is vital for reproducibility and purity in electronic-grade small molecules and polymer precursors. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Advanced Materials – Liquid Crystal and Polymeric Material SynthesisMaterial scientists utilize this compound when synthesizing difluorinated aromatic segments in liquid crystals and advanced fluoropolymer backbones. Its structural precision and batching stability facilitate the production of high-performance polymers for specialized optical and display applications, meeting strict commercial specifications for purity and molecular weight distribution. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Fine Chemical Building Blocks for Medicinal ChemistryChemical research organizations and custom synthesis teams make extensive use of this building block to create libraries of substituted aryl compounds. Its unique substitution pattern is valued when synthesizing novel fluorinated analogues for early-stage medicinal chemistry, ADME profiling, and patentable new entities. Purity, lot history, and rapid response support are essential for these R&D programs. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 4-Bromo-2,3-Difluorobenzeneboronic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Manufacturing specialized boronic acids comes with unique challenges that go beyond regular fine chemical production. Over years of hands-on experience, we have learned that attention to purification, repeatability in production runs, and close tracking of impurities at every step matter just as much as the technical understanding of the chemistry. In the case of 4-Bromo-2,3-difluorobenzeneboronic acid, the stakes are higher than usual. This molecule, with its specific halogen pattern on the aromatic core, serves as a differentiated building block for complex molecule synthesis. Chemists trust that every bottle contains exactly what the label says, free from unknown isomers or halogen-exchange byproducts.
Demand for this compound marks the ongoing trend toward molecular customization in pharmaceutical discovery and advanced material research. Medicinal chemists often need non-symmetrical boronates with defined substitution for Suzuki-Miyaura cross-coupling, and the bromo-difluorophenyl moiety enables selective coupling at a specific location—a detail that can advance a drug program past early hit stages. Fluorine atoms regulate the electron density in the aromatic ring, influence metabolic stability, and sometimes lead to promising bioactivity changes in pursuit of novel drug molecules. For electronics and polymer scientists, difluorinated boronic acids introduce desired properties like reduced oxidation potential and improved tunability for device performance.
Each batch starts with sourcing high-quality halogenated aromatic blocks. Boronation reactions, especially on multiply-substituted arenes, require precise conditions for clean conversion. Temperature ramps, controlled addition rates, and rigorous exclusion of water or atmospheric oxygen all become central. Once boronation is complete, purification must remove both inorganic byproducts and closely related organic impurities. Years of scaling up have taught us that small changes—variation in anhydrous solvents, slight catalyst impurities, or storage condition fluctuations—can tip yields or create hard-to-detect impurities. These learnings go into every batch we sign off, and we retest archive samples to confirm long-term shelf stability.
Our commitment always goes beyond finishing a reaction and collecting product. Each lot of 4-Bromo-2,3-difluorobenzeneboronic acid undergoes a battery of analyses: HPLC purity, 1H/13C/19F NMR, mass spectrometry, and specific impurity assays based on application. For customers working under GMP conditions, we can provide additional trace metal analysis and extra verification of residual solvents—crucial for pharmaceutical development where every contaminant might influence a lead candidate’s profile. Our internal standards dictate rejection of any batch with measurable bromo-isomers or hydrolysis products, meaning researchers receive a chemically well-defined input for each synthesis run.
Most users expect a free-flowing, white to off-white crystalline powder. In practice, actual appearance can tell a lot about product handling—yellowing suggests trace decomposition, while excessive caking might come from excess moisture. Our process achieves moisture-controlled product in easy-to-handle packaging, reducing headaches both at high-throughput screening scales and R&D batch runs. Particle size distribution influences how powders dissolve and mix. Laboratory chemists who require rapid substrate dissolution for automated screening, and process chemists working on scale-up, both benefit from our ongoing efforts to improve crystalline texture and storage stability.
Feedback from research groups and scale-up partners shapes each manufacturing adjustment. Initially, subtle changes—like a drier, more compact crystal—reduced clumping during winter shipments. A few small customizations in drying conditions and container choices eliminated complaint tickets over inconsistent pourability, freeing up both our chemists and customer teams for their actual work. Time in the field has shown that regular dialogue with end users, from medicinal chemists in biotech startups to procurement managers at large pharma companies, identifies both real hurdles and simple, often overlooked improvements.
Many boronic acids seem interchangeable at a quick glance, especially if comparing products strictly by assay or purity number. The substitution pattern across the aromatic core makes a world of difference in coupling efficiency, byproduct tendencies, and downstream ease of purification. 4-Bromo-2,3-difluorobenzoic acid has more electron-withdrawing power than mono-fluorinated or mono-brominated cousins. This changes its reactivity profile, making some cross-couplings calmer, with fewer homocoupling side reactions, while enabling milder activation conditions. Synthetic chemists comment that these differences cut hours of troubleshooting off project timelines.
The presence of two fluorines at the 2,3-positions, paired with the meta-bromo placement, opens the door for regioselective reactions. Custom molecules for kinase inhibitors, PET imaging agents, and novel OLED materials have all relied on our shipments of this compound. One partner required kilogram lots for an API intermediate, demanding both consistency and documentation for regulatory filings. Several electronics manufacturers sought small, ultra-pure samples for materials library construction, proving that bulk and boutique needs both emerge. Startups and established labs alike look for reliability, responsive technical support, and transparency in supply chain integrity.
Working at the source grants us direct visibility into every lot’s production history. We maintain complete batch records, analytic data, and long-term storage test samples, ensuring traceability—not only for our peace of mind but for researchers facing regulatory questions. Whether customers approach us with questions about a specific spectral peak or a concern about previous supply consistency, we draw on real evidence, not vague assurances, and work collaboratively toward resolution. In fast-moving research environments, clear and open communication complements provision of materials with transparent, verifiable histories.
Manufacturers see the real impact of safety policies, training, and quality systems every day. 4-Bromo-2,3-difluorobenzeneboronic acid, like many aromatic boronic acids, requires protection from moisture and high temperatures to maintain shelf life and performance in synthesis. We rely on strict protocols for packaging—using high-barrier liners, labeling with handling requirements, and training shipping partners to keep material dry and stable. Customers regularly share stories where proper packaging meant the difference between sure-fire reactions and failed experiments. These stories reinforce why full accountability from the production floor to the customer site matters.
Every batch brings the reality of hazardous waste management and resource consumption into sharp relief. We continually invest in greener options—optimization of solvent usage, recycling and reclamation strategies, and minimization of waste streams in halogen and boron chemistry. By implementing solvent recovery and adopting reaction conditions that cut down on caustic byproducts, our manufacturing lines reduce environmental footprint. Close monitoring and compliance with local and international standards assures users that their supply chain adheres to recognized environmental benchmarks.
Supplying directly from the production site, rather than through intermediaries, means complete control. There are fewer unknowns about stock origin, shelf life, or product variability. Any supply disruption becomes a shared problem with rapid, well-informed troubleshooting at both ends. Chemists working in time-sensitive projects value the access to real technical feedback—not just from a sales desk, but from the hands that made the compound. Our customers comment on the predictability that comes with such relationships, whether in everyday order fulfillment or in accommodating custom requests.
Production of narrow-spec boronic acids evolved greatly thanks to advances in catalytic methodologies and analytical technology. As demand accelerates, our strategy emphasizes training, retention, and development of skilled chemists and operators. Investment in new analytical tools—like real-time LCMS monitoring and advanced process controllers—enhances ability to catch issues early and produce more reliable product lots. This mindset, marrying established experience to technological progress, drives every decision about scaling up or branching into new related targets.
Disruptions—whether due to global transportation delays, shifts in raw material prices, or regulatory interpretations—affect every specialty producer. Maintaining strong, diversified supplier relationships, and stocking critical intermediates, lessens the possibility of customer shortages. Open, honest updates during changing economic or policy conditions reinforce trust that was built over years of regular supply. Our dedication to end-to-end integrity, along with resilient logistics strategies, helps support innovators from nascent academic labs to multi-national research hubs.
Beyond every shipment lies a community of chemists, procurement experts, environmental officers, and business partners. Our understanding goes deeper than technical specifications. When a customer proposes a new synthesis or brings up an unexpected result, we work as problem solvers and advisors, sharing lessons learned in dozens of previous projects. The relationship often extends from a single order to joint troubleshooting, sourcing hard-to-find analogs, or supporting on-site audits for regulated manufacturing. The personal relationships and mutual respect that grow from these ongoing collaborations benefit every new user and project team.
Increasing pressure to develop specialty molecules more quickly, at scale, and under tighter regulatory scrutiny changes what it means to be a chemical producer. Investments in automation, better process analytical tools, and sustainability initiatives open doors to faster, more flexible production while raising the bar for reporting and documentation. Challenges like new EU REACH restrictions, tighter US export controls, or sudden supply shocks must be navigated not just with contingency plans, but with the agility that a direct producer enjoys. As the field of custom organic synthesis grows, our role as both makers and partners becomes more central—ensuring every customer can take their ideas from benchtop to market with confidence.
For every user, from the lone scientist tackling a late-stage synthetic challenge to multidisciplinary teams engineering the next generation of medicines, consistency in quality translates directly into saved resources, avoided failures, and breakthroughs realized. Stories from the lab benches of biotech startups, university research groups, and pharmaceutical development teams reach back to us, illustrating how a carefully made bottle of 4-Bromo-2,3-difluorobenzeneboronic acid sped up a lead optimization campaign, solved a stubborn selectivity issue, or met critical purity requirements for regulatory submission. These successes validate the painstaking work performed at every level of our manufacturing process.
Working day in and day out in specialty manufacturing leaves little room for complacency. Even as established protocols deliver reliable product, new feedback, challenging applications, or changes in underlying science drive each process review. Our chemists readily share in the pride that comes from solving tough isolation problems or pushing for better, cleaner, faster ways to produce such a versatile compound. This shared pride, invested in each employee from production management to final QA, turns a simple chemical name into a trusted solution for researchers and businesses worldwide.
Sustained investment in greener chemistry, smarter analytics, and collaborative approaches to problem-solving means the manufacture of 4-Bromo-2,3-difluorobenzeneboronic acid only improves with time. Our journey as direct producers provides unique insights—both technical and human—that reinforce shared goals with each user pushing the boundaries of molecular science. As new challenges arise, adaptability and a knowledge-driven approach remain our foundation.